Activation of group III metabotropic glutamate receptors in selected regions of the basal ganglia alleviates akinesia in the reserpine-treated rat

British Journal of Pharmacology

Volumn 141, Issue 1, 2004, Pages 15-22

  MacInnes, Nicholas ^a   Messenger, Marcus J ^a   Duty, Susan ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Akinesia; Globus pallidus; Group III metabotropic glutamate receptors; in vivo; Parkinson's disease; Rat; Reserpine; Substantia nigra pars reticulata

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR AGONIST; METABOTROPIC RECEPTOR ANTAGONIST; METHYLSERINE O PHOSPHATE; PHOSPHOSERINE; RESERPINE; UNCLASSIFIED DRUG;

AKINESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

AMINOBUTYRIC ACIDS; ANIMALS; CEREBRAL VENTRICLES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLOBUS PALLIDUS; GLUTAMIC ACID; HYPOKINESIA; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SUBCUTANEOUS; MALE; MOVEMENT; PHOSPHOSERINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RESERPINE; ROTATION; SUBSTANTIA NIGRA;

EID: 1242341372     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705566     Document Type: Article

References (28)

1. BLANDINI, F., NAPPI, G., TASSORELLI, C. & MARTIGNONI, E. (2000). Functional changes of the basal ganglia circuitry in Parkinson's disease. Prog. Neurobiol., 62, 63-88.
2. BRADLEY, S.R., MARINO, M.J., WITTMANN, M., ROUSE, S.T., AWAD, H., LEVEY, A.I. & CONN, P.J. (2000). Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia nigra pars reticulata. J. Neurosci., 20, 3085-3094.
3. BRADLEY, S.R., STANDAERT, D.G., LEVEY, A.I. & CONN, P.J. (1999a). Distribution of group III mGluRs in rat basal ganglia with subtype-specific antibodies. Ann. NY Acad. Sci., 868, 531-534.
4. BRADLEY, S.R., STANDAERT, D.G., RHODES, K.J., REES, H.D., TESTA, C.M., LEVEY, A.I. & CONN, P.J. (1999b). Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia. J. Comp. Neurol., 407, 33-46.
5. 3H]-GABA release from rat globus pallidus slices and reverses akinesia following intrapallidal injection in the reserpine-treated rat. Br. J. Pharmacol., 130, 1927-1932.
6. 3H]Ro 15-788 binding in rat globus pallidus and substantia nigra pars reticulata following a nigrostriatal tract lesion. Brain Res., 862, 280-283.
7. CONN, P.J. & PIN, J.P. (1997). Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol., 37, 205-237.
8. DAWSON, L., CHADHA, A., MEGALOU, M. & DUTY, S. (2000). The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat. Br. J. Pharmacol., 129, 541-546.
9. B receptor agonists reverse akinesia following intranigral and intracerebroventricular injection in the reserpine-treated rat. Br. J. Pharmacol., 139, 1480-1486.
10. KOSINSKI, C.M., RISSO BRADLEY, S., CONN, P.J., LEVEY, A.I., LANDWEHRMEYER, G.B., PENNEY JR, J.B., YOUNG, A.B. & STANDAERT, D.G. (1999). Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia. J. Comp. Neurol., 415, 266-284.
11. LEVY, R., HAZRATI, L.N., HERRERO, M.T., VILA, M., HASSANI, O.K., MOUROUX, M., RUBERG, M., ASENSI, H., AGID, Y., FEGER, J., OBESO, J.A., PARENT, A. & HIRSCH, E.C. (1997). Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience, 76, 335-343.
12. LOZANO, A.M. (2003). Surgery for Parkinson's disease, the five W's: why, who, what, where, and when. Adv. Neurol., 91, 303-307.
13. MACINNES, N. & DUTY, S. (2003). Intraventricular and intrapallidial injections of the group III metabotropic glutamate receptor agonist L-serine-O-phosphate (L-SOP) alleviate reserpine-induced akinesia in the rat. Br. J. Pharmacol., 138, 226p.
14. MESSENGER, M., DAWSON, L. & DUTY, S. (2002). Changes in metabotropic glutamate receptor 1-8 gene expression in the rodent basal ganglia motor loop following lesion of the nigrostriatal tract. Neuropharmacology, 43, 261-271.
15. 3H]D-aspartate release from rat nigral slices. Br. J. Pharmacol., 1, 14p.
16. OBESO, J.A., RODRIGUEZ-OROZ, M.C., RODRIGUEZ, M., LANCIEGO, J.L., ARTIEDA, J., GONZALO, N. & OLANOW, C.W. (2000). Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci., 23, S8-S19.
17. PAN, H.S., PENNEY, J.B. & YOUNG, A.B. (1985). Aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the median forebrain bundle. J. Neurochem., 45, 1396-1404.
18. PARENT, A. & HAZRATI, L.N. (1995a). Functional anatomy of the basal ganglia I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Brain Res. Rev., 20, 91-127.
19. PARENT, A. & HAZRATI, L.N. (1995b). Functional anatomy of the basal ganglia II. The place of the subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res. Brain Res. Rev., 20, 128-154.
20. PAXINOS, G. & WATSON, C. (1986). The Rat Brain in Stereotaxic Co-Ordinates. UK: Academic Press.
21. SEGOVIA, J., TOSSMAN, U., HERRERA-MARSCHITZ, M., GARCIA-MUNOZ, M. & UNGERSTEDT, U. (1986). Gamma-Aminobutyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat. Neurosci. Lett., 70, 364-368.
22. B and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones. J. Physiol. (Lond)., 505 (Part 1), 153-163.
23. STOCCHI, F., NORDERA, G. & MARSDEN, C.D. (1997). Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias. Clin. Neuropharmacol., 20, 95-115.
24. THOMAS, N.K., JANE, D.E., TSE, H.W. & WATKINS, J.C. (1996). Alpha-methyl derivatives of serine-O-phosphate as novel, selective competitive metabotopic glutamate receptor antagonists. Neuropharmacology, 35, 637-642.
25. VALENTI, O., MARINO, M.J., WITTMAN, M., LIS, E., DILELLA, A.G., KINNEY, G.G. & CONN, P.J. (2003). Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse. J. Neurosci., 23, 7218-7226.
26. WITTMANN, M., MARINO, M.J. & CONN, P.J. (2002). Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata. J. Pharmacol. Exp. Ther., 302, 433-441.
27. YIP, P.K., MELDRUM, B.S. & RATTRAY, M. (2001). Elevated levels of group-III metabotropic glutamate receptors in the inferior colliculus of genetically epilepsy-prone rats following intracollicular administration of l-serine-O-phosphate. J. Neurochem., 78, 13-23.
28. YOU, Z.-B., HERRERA-MARSCHITZ, M., PETTERSSON, E., NYLANDER, I., GOINY, M., SHOU, H.Z., KEHR, J., GOUDUKHIN, O., HOKFELT, T., TERENIUS, L. & UNGERSTEDT, U. (1996). Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specifity. Neuroscience, 74, 793-804.